<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-07-25" modified="2017-05-10" version="175">
<accession>Q92614</accession>
<accession>Q5H9U3</accession>
<accession>Q5QD01</accession>
<accession>Q5W9F9</accession>
<accession>Q5W9G1</accession>
<accession>Q8IXP8</accession>
<name>MY18A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Unconventional myosin-XVIIIa</fullName>
</recommendedName>
<alternativeName>
<fullName>Molecule associated with JAK3 N-terminus</fullName>
<shortName>MAJN</shortName>
</alternativeName>
<alternativeName>
<fullName>Myosin containing a PDZ domain</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="29">Surfactant protein receptor SP-R210</fullName>
<shortName evidence="29">SP-R210</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">MYO18A</name>
<name type="synonym" evidence="31">CD245</name>
<name type="synonym">KIAA0216</name>
<name type="synonym">MYSPDZ</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2004" name="J. Mol. Biol." volume="343" first="1207" last="1220">
<title>Alternative splice variants encoding unstable protein domains exist in the human brain.</title>
<authorList>
<person name="Homma K."/>
<person name="Kikuno R.F."/>
<person name="Nagase T."/>
<person name="Ohara O."/>
<person name="Nishikawa K."/>
</authorList>
<dbReference type="PubMed" id="15491607"/>
<dbReference type="DOI" id="10.1016/j.jmb.2004.09.028"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 9-2054 (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="34447" last="34457">
<title>Identification of the surfactant protein A receptor 210 as the unconventional myosin 18A.</title>
<authorList>
<person name="Yang C.H."/>
<person name="Szeliga J."/>
<person name="Jordan J."/>
<person name="Faske S."/>
<person name="Sever-Chroneos Z."/>
<person name="Dorsett B."/>
<person name="Christian R.E."/>
<person name="Settlage R.E."/>
<person name="Shabanowitz J."/>
<person name="Hunt D.F."/>
<person name="Whitsett J.A."/>
<person name="Chroneos Z.C."/>
</authorList>
<dbReference type="PubMed" id="16087679"/>
<dbReference type="DOI" id="10.1074/jbc.M505229200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>VARIANT VAL-958</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="DNA Res." volume="3" first="321" last="329">
<title>Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain.</title>
<authorList>
<person name="Nagase T."/>
<person name="Seki N."/>
<person name="Ishikawa K."/>
<person name="Ohira M."/>
<person name="Kawarabayasi Y."/>
<person name="Ohara O."/>
<person name="Tanaka A."/>
<person name="Kotani H."/>
<person name="Miyajima N."/>
<person name="Nomura N."/>
</authorList>
<dbReference type="PubMed" id="9039502"/>
<dbReference type="DOI" id="10.1093/dnares/3.5.321"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT VAL-958</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)</scope>
<source>
<tissue>Amygdala</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
<scope>VARIANT VAL-958</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2000" name="Biochem. Biophys. Res. Commun." volume="270" first="267" last="271">
<title>A novel protein MAJN binds to Jak3 and inhibits apoptosis induced by IL-2 deprival.</title>
<authorList>
<person name="Ji H."/>
<person name="Zhai Q."/>
<person name="Zhu J."/>
<person name="Yan M."/>
<person name="Sun L."/>
<person name="Liu X."/>
<person name="Zheng Z."/>
</authorList>
<dbReference type="PubMed" id="10733938"/>
<dbReference type="DOI" id="10.1006/bbrc.2000.2413"/>
</citation>
<scope>INTERACTION WITH JAK3</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="J. Biochem." volume="133" first="405" last="413">
<title>Genome structure and differential expression of two isoforms of a novel PDZ-containing myosin (MysPDZ) (Myo18A).</title>
<authorList>
<person name="Mori K."/>
<person name="Furusawa T."/>
<person name="Okubo T."/>
<person name="Inoue T."/>
<person name="Ikawa S."/>
<person name="Yanai N."/>
<person name="Mori K.J."/>
<person name="Obinata M."/>
</authorList>
<dbReference type="PubMed" id="12761286"/>
<dbReference type="DOI" id="10.1093/jb/mvg053"/>
</citation>
<scope>ALTERNATIVE SPLICING (ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2005" name="Biochemistry" volume="44" first="6190" last="6196">
<title>The N-terminal domain of MYO18A has an ATP-insensitive actin-binding site.</title>
<authorList>
<person name="Isogawa Y."/>
<person name="Kon T."/>
<person name="Inoue T."/>
<person name="Ohkura R."/>
<person name="Yamakawa H."/>
<person name="Ohara O."/>
<person name="Sutoh K."/>
</authorList>
<dbReference type="PubMed" id="15835906"/>
<dbReference type="DOI" id="10.1021/bi0475931"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>HOMODIMERIZATION</scope>
<scope>INTERACTION WITH ACTIN</scope>
<scope>MUTAGENESIS OF 114-ARG-GLY-115 AND 117-VAL-LEU-118</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1970 AND SER-1974</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2008" name="Cell" volume="135" first="123" last="136">
<title>A tripartite complex containing MRCK modulates lamellar actomyosin retrograde flow.</title>
<authorList>
<person name="Tan I."/>
<person name="Yong J."/>
<person name="Dong J.M."/>
<person name="Lim L."/>
<person name="Leung T."/>
</authorList>
<dbReference type="PubMed" id="18854160"/>
<dbReference type="DOI" id="10.1016/j.cell.2008.09.018"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH LURAP1 AND CDC42BPA/CDC42BPB</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2020</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1070; SER-1998; SER-2002; SER-2020; SER-2041; SER-2043 AND THR-2045</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Proteomics" volume="8" first="1346" last="1361">
<title>Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography.</title>
<authorList>
<person name="Han G."/>
<person name="Ye M."/>
<person name="Zhou H."/>
<person name="Jiang X."/>
<person name="Feng S."/>
<person name="Jiang X."/>
<person name="Tian R."/>
<person name="Wan D."/>
<person name="Zou H."/>
<person name="Gu J."/>
</authorList>
<dbReference type="PubMed" id="18318008"/>
<dbReference type="DOI" id="10.1002/pmic.200700884"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1970 AND SER-1974</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Cell" volume="139" first="337" last="351">
<title>GOLPH3 bridges phosphatidylinositol-4- phosphate and actomyosin to stretch and shape the Golgi to promote budding.</title>
<authorList>
<person name="Dippold H.C."/>
<person name="Ng M.M."/>
<person name="Farber-Katz S.E."/>
<person name="Lee S.K."/>
<person name="Kerr M.L."/>
<person name="Peterman M.C."/>
<person name="Sim R."/>
<person name="Wiharto P.A."/>
<person name="Galbraith K.A."/>
<person name="Madhavarapu S."/>
<person name="Fuchs G.J."/>
<person name="Meerloo T."/>
<person name="Farquhar M.G."/>
<person name="Zhou H."/>
<person name="Field S.J."/>
</authorList>
<dbReference type="PubMed" id="19837035"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.07.052"/>
</citation>
<scope>FUNCTION IN GOLGI MEMBRANE BUDDING</scope>
<scope>INTERACTION WITH GOLPH3</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2041 AND SER-2043</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83; SER-140; SER-2041 AND SER-2043</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="4854" last="4870">
<title>Surfactant protein A (SP-A)-mediated clearance of Staphylococcus aureus involves binding of SP-A to the staphylococcal adhesin eap and the macrophage receptors SP-A receptor 210 and scavenger receptor class A.</title>
<authorList>
<person name="Sever-Chroneos Z."/>
<person name="Krupa A."/>
<person name="Davis J."/>
<person name="Hasan M."/>
<person name="Yang C.H."/>
<person name="Szeliga J."/>
<person name="Herrmann M."/>
<person name="Hussain M."/>
<person name="Geisbrecht B.V."/>
<person name="Kobzik L."/>
<person name="Chroneos Z.C."/>
</authorList>
<dbReference type="PubMed" id="21123169"/>
<dbReference type="DOI" id="10.1074/jbc.M110.125567"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140; SER-1970; SER-2007; SER-2041 AND SER-2043</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="30029" last="30041">
<title>Functional Characterization of Human Myosin-18A and its Interaction with F-actin and GOLPH3.</title>
<authorList>
<person name="Taft M.H."/>
<person name="Behrmann E."/>
<person name="Munske-Weidemann L.C."/>
<person name="Thiel C."/>
<person name="Raunser S."/>
<person name="Manstein D.J."/>
</authorList>
<dbReference type="PubMed" id="23990465"/>
<dbReference type="DOI" id="10.1074/jbc.M113.497180"/>
</citation>
<scope>INTERACTION WITH GOLPH3</scope>
<scope>F-ACTIN-BINDING</scope>
<scope>NUCLEOTIDE-BINDING</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35; SER-52; SER-72; SER-74; SER-83; SER-145; SER-164; SER-234; SER-1640; SER-1843; SER-1970; SER-2007; SER-2020; SER-2041 AND SER-2043</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2013" name="Mol. Biol. Cell" volume="24" first="796" last="808">
<title>GOLPH3L antagonizes GOLPH3 to determine Golgi morphology.</title>
<authorList>
<person name="Ng M.M."/>
<person name="Dippold H.C."/>
<person name="Buschman M.D."/>
<person name="Noakes C.J."/>
<person name="Field S.J."/>
</authorList>
<dbReference type="PubMed" id="23345592"/>
<dbReference type="DOI" id="10.1091/mbc.E12-07-0525"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH GOLPH3</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-79; SER-98; THR-99; SER-103; SER-140; SER-234; SER-1067; SER-1068; SER-1640; SER-1942; SER-1970; SER-1974; SER-1998; SER-2002; SER-2006; SER-2014; SER-2020; TYR-2035; SER-2041 AND SER-2043</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1922 (ISOFORM 3)</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1959 (ISOFORM 4)</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1501 (ISOFORM 5)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0126576" last="E0126576">
<title>SP-R210 (Myo18A) isoforms as intrinsic modulators of macrophage priming and activation.</title>
<authorList>
<person name="Yang L."/>
<person name="Carrillo M."/>
<person name="Wu Y.M."/>
<person name="DiAngelo S.L."/>
<person name="Silveyra P."/>
<person name="Umstead T.M."/>
<person name="Halstead E.S."/>
<person name="Davies M.L."/>
<person name="Hu S."/>
<person name="Floros J."/>
<person name="McCormack F.X."/>
<person name="Christensen N.D."/>
<person name="Chroneos Z.C."/>
</authorList>
<dbReference type="PubMed" id="25965346"/>
<dbReference type="DOI" id="10.1371/journal.pone.0126576"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MSR1; CD14 AND CD11B</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2016" name="OncoImmunology" volume="5" first="E1127493" last="E1127493">
<title>Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes.</title>
<authorList>
<person name="De Masson A."/>
<person name="Giustiniani J."/>
<person name="Marie-Cardine A."/>
<person name="Bouaziz J.D."/>
<person name="Dulphy N."/>
<person name="Gossot D."/>
<person name="Validire P."/>
<person name="Tazi A."/>
<person name="Garbar C."/>
<person name="Bagot M."/>
<person name="Merrouche Y."/>
<person name="Bensussan A."/>
</authorList>
<dbReference type="PubMed" id="27467939"/>
<dbReference type="DOI" id="10.1080/2162402X.2015.1127493"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<comment type="function">
<text evidence="11 18 19 20 21 22 24 25">May link Golgi membranes to the cytoskeleton and participate in the tensile force required for vesicle budding from the Golgi. Thereby, may play a role in Golgi membrane trafficking and could indirectly give its flattened shape to the Golgi apparatus (PubMed:19837035, PubMed:23345592). Alternatively, in concert with LURAP1 and CDC42BPA/CDC42BPB, has been involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration (PubMed:18854160). May be involved in the maintenance of the stromal cell architectures required for cell to cell contact (By similarity). Regulates trafficking, expression, and activation of innate immune receptors on macrophages. Plays a role to suppress inflammatory responsiveness of macrophages via a mechanism that modulates CD14 trafficking (PubMed:25965346). Acts as a receptor of surfactant-associated protein A (SFTPA1/SP-A) and plays an important role in internalization and clearance of SFTPA1-opsonized S.aureus by alveolar macrophages (PubMed:16087679, PubMed:21123169). Strongly enhances natural killer cell cytotoxicity (PubMed:27467939).</text>
</comment>
<comment type="subunit">
<text evidence="15 17 19 20 22 23 24">Homodimer. Forms a tripartite complex with CDC42BPA/CDC42BPB and LURAP1 with the latter acting as an adapter connecting CDC42BPA/CDC42BPB and MYO18A. Binds F-actin; regulated by ADP and GOLPH3. Interacts with GOLPH3; the interaction is direct and may link Golgi membranes to the actin cytoskeleton. Interacts with JAK3. Interacts with MSR1 and CD14 (PubMed:25965346). Isoform 5 interacts with CD11B (PubMed:25965346).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-949059"/>
<interactant intactId="EBI-2465479">
<id>Q9H4A6</id>
<label>GOLPH3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location evidence="10">Endoplasmic reticulum-Golgi intermediate compartment</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
</subcellularLocation>
<text>Colocalizes with actin.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Lacks the PDZ domain. Diffusely localized in the cytoplasm.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Golgi apparatus</location>
</subcellularLocation>
<subcellularLocation>
<location>Golgi apparatus</location>
<location>trans-Golgi network</location>
</subcellularLocation>
<text>Recruited to the Golgi apparatus by GOLPH3.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 5</molecule>
<subcellularLocation>
<location evidence="18">Cell surface</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q92614-1</id>
<name>1</name>
<name>Alpha</name>
<name evidence="29">SP-R210L</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q92614-2</id>
<name>2</name>
<name>Beta</name>
<sequence type="described" ref="VSP_007869 VSP_007870"/>
</isoform>
<isoform>
<id>Q92614-3</id>
<name>3</name>
<sequence type="described" ref="VSP_007871 VSP_007872"/>
<text evidence="9">No experimental confirmation available. Contains a phosphoserine at position 1922.</text>
</isoform>
<isoform>
<id>Q92614-4</id>
<name>4</name>
<sequence type="described" ref="VSP_007872"/>
<text evidence="9">No experimental confirmation available. Contains a phosphoserine at position 1959.</text>
</isoform>
<isoform>
<id>Q92614-5</id>
<name>5</name>
<name evidence="29">SP-R210S</name>
<sequence type="described" ref="VSP_023058 VSP_007872"/>
<text evidence="9">Contains a phosphoserine at position 1501.</text>
</isoform>
</comment>
<comment type="domain">
<text evidence="23">The myosin motor domain binds ADP and ATP but has no intrinsic ATPase activity. Mediates ADP-dependent binding to actin (PubMed:23990465).</text>
</comment>
<comment type="similarity">
<text evidence="32">Belongs to the TRAFAC class myosin-kinesin ATPase superfamily. Myosin family.</text>
</comment>
<comment type="caution">
<text evidence="32">The TIAF1 protein is coded in the 3'-UTR region of MYO18A.</text>
</comment>
<comment type="sequence caution" evidence="32">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA13206" version="2"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="32">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAD66838" version="1"/>
</conflict>
</comment>
<dbReference type="EMBL" id="AB177858">
<property type="protein sequence ID" value="BAD66836.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB177860">
<property type="protein sequence ID" value="BAD66838.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY703984">
<property type="protein sequence ID" value="AAV80770.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D86970">
<property type="protein sequence ID" value="BAA13206.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR933614">
<property type="protein sequence ID" value="CAI45931.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC039612">
<property type="protein sequence ID" value="AAH39612.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45641.1">
<molecule id="Q92614-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45642.1">
<molecule id="Q92614-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001333696.1">
<molecule id="Q92614-3"/>
<property type="nucleotide sequence ID" value="NM_001346767.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001333697.1">
<molecule id="Q92614-5"/>
<property type="nucleotide sequence ID" value="NM_001346768.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_510880.2">
<molecule id="Q92614-1"/>
<property type="nucleotide sequence ID" value="NM_078471.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_976063.1">
<molecule id="Q92614-4"/>
<property type="nucleotide sequence ID" value="NM_203318.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.462590"/>
<dbReference type="ProteinModelPortal" id="Q92614"/>
<dbReference type="SMR" id="Q92614"/>
<dbReference type="BioGrid" id="134384">
<property type="interactions" value="176"/>
</dbReference>
<dbReference type="DIP" id="DIP-46631N"/>
<dbReference type="IntAct" id="Q92614">
<property type="interactions" value="159"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000437073"/>
<dbReference type="iPTMnet" id="Q92614"/>
<dbReference type="PhosphoSitePlus" id="Q92614"/>
<dbReference type="SwissPalm" id="Q92614"/>
<dbReference type="BioMuta" id="MYO18A"/>
<dbReference type="DMDM" id="33301318"/>
<dbReference type="EPD" id="Q92614"/>
<dbReference type="MaxQB" id="Q92614"/>
<dbReference type="PaxDb" id="Q92614"/>
<dbReference type="PeptideAtlas" id="Q92614"/>
<dbReference type="PRIDE" id="Q92614"/>
<dbReference type="Ensembl" id="ENST00000527372">
<molecule id="Q92614-1"/>
<property type="protein sequence ID" value="ENSP00000437073"/>
<property type="gene ID" value="ENSG00000196535"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000531253">
<molecule id="Q92614-4"/>
<property type="protein sequence ID" value="ENSP00000434228"/>
<property type="gene ID" value="ENSG00000196535"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000533112">
<molecule id="Q92614-3"/>
<property type="protein sequence ID" value="ENSP00000435932"/>
<property type="gene ID" value="ENSG00000196535"/>
</dbReference>
<dbReference type="GeneID" id="399687"/>
<dbReference type="KEGG" id="hsa:399687"/>
<dbReference type="UCSC" id="uc002hdt.2">
<molecule id="Q92614-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="399687"/>
<dbReference type="DisGeNET" id="399687"/>
<dbReference type="GeneCards" id="MYO18A"/>
<dbReference type="HGNC" id="HGNC:31104">
<property type="gene designation" value="MYO18A"/>
</dbReference>
<dbReference type="HPA" id="HPA019646"/>
<dbReference type="HPA" id="HPA021121"/>
<dbReference type="MIM" id="609517">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="610067">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q92614"/>
<dbReference type="OpenTargets" id="ENSG00000196535"/>
<dbReference type="PharmGKB" id="PA134978348"/>
<dbReference type="eggNOG" id="KOG0161">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5022">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00870000136475"/>
<dbReference type="HOGENOM" id="HOG000113701"/>
<dbReference type="HOVERGEN" id="HBG052543"/>
<dbReference type="InParanoid" id="Q92614"/>
<dbReference type="KO" id="K10362"/>
<dbReference type="OMA" id="IPRPGHR"/>
<dbReference type="OrthoDB" id="EOG091G00GA"/>
<dbReference type="PhylomeDB" id="Q92614"/>
<dbReference type="TreeFam" id="TF339614"/>
<dbReference type="Reactome" id="R-HSA-1839117">
<property type="pathway name" value="Signaling by cytosolic FGFR1 fusion mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5655302">
<property type="pathway name" value="Signaling by FGFR1 in disease"/>
</dbReference>
<dbReference type="ChiTaRS" id="MYO18A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="MYO18A"/>
<dbReference type="GenomeRNAi" id="399687"/>
<dbReference type="PRO" id="PR:Q92614"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000196535"/>
<dbReference type="CleanEx" id="HS_MYO18A"/>
<dbReference type="ExpressionAtlas" id="Q92614">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q92614">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0042641">
<property type="term" value="C:actomyosin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005793">
<property type="term" value="C:endoplasmic reticulum-Golgi intermediate compartment"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0000139">
<property type="term" value="C:Golgi membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016459">
<property type="term" value="C:myosin complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005802">
<property type="term" value="C:trans-Golgi network"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051015">
<property type="term" value="F:actin filament binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043531">
<property type="term" value="F:ADP binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031032">
<property type="term" value="P:actomyosin structure organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090164">
<property type="term" value="P:asymmetric Golgi ribbon formation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0016477">
<property type="term" value="P:cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006259">
<property type="term" value="P:DNA metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0007030">
<property type="term" value="P:Golgi organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090161">
<property type="term" value="P:Golgi ribbon formation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0048194">
<property type="term" value="P:Golgi vesicle budding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:1903028">
<property type="term" value="P:positive regulation of opsonization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050714">
<property type="term" value="P:positive regulation of protein secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043030">
<property type="term" value="P:regulation of macrophage activation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR000048">
<property type="entry name" value="IQ_motif_EF-hand-BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR031244">
<property type="entry name" value="MYO18A"/>
</dbReference>
<dbReference type="InterPro" id="IPR001609">
<property type="entry name" value="Myosin_head_motor_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR002928">
<property type="entry name" value="Myosin_tail"/>
</dbReference>
<dbReference type="InterPro" id="IPR027417">
<property type="entry name" value="P-loop_NTPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR001478">
<property type="entry name" value="PDZ"/>
</dbReference>
<dbReference type="InterPro" id="IPR020587">
<property type="entry name" value="RecA_monomer-monomer_interface"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR13140:SF575">
<property type="entry name" value="PTHR13140:SF575"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00063">
<property type="entry name" value="Myosin_head"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01576">
<property type="entry name" value="Myosin_tail_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00595">
<property type="entry name" value="PDZ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00193">
<property type="entry name" value="MYOSINHEAVY"/>
</dbReference>
<dbReference type="SMART" id="SM00015">
<property type="entry name" value="IQ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00242">
<property type="entry name" value="MYSc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00228">
<property type="entry name" value="PDZ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50156">
<property type="entry name" value="SSF50156"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52540">
<property type="entry name" value="SSF52540"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50096">
<property type="entry name" value="IQ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51456">
<property type="entry name" value="MYOSIN_MOTOR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50106">
<property type="entry name" value="PDZ"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0505">Motor protein</keyword>
<keyword id="KW-0518">Myosin</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<feature type="chain" description="Unconventional myosin-XVIIIa" id="PRO_0000123476">
<location>
<begin position="1"/>
<end position="2054"/>
</location>
</feature>
<feature type="domain" description="PDZ" evidence="14">
<location>
<begin position="220"/>
<end position="311"/>
</location>
</feature>
<feature type="domain" description="Myosin motor">
<location>
<begin position="405"/>
<end position="1185"/>
</location>
</feature>
<feature type="domain" description="IQ" evidence="13">
<location>
<begin position="1188"/>
<end position="1217"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="12">
<location>
<begin position="498"/>
<end position="505"/>
</location>
</feature>
<feature type="region of interest" description="Mediates nucleotide-independent binding to F-actin and interaction with GOLPH3">
<location>
<begin position="1"/>
<end position="398"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="12">
<location>
<begin position="1246"/>
<end position="1971"/>
</location>
</feature>
<feature type="short sequence motif" description="Interaction with actin">
<location>
<begin position="114"/>
<end position="118"/>
</location>
</feature>
<feature type="compositionally biased region" description="Lys-rich">
<location>
<begin position="6"/>
<end position="25"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="35"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="52"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="72"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="74"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9">
<location>
<position position="79"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 8">
<location>
<position position="83"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="98"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9">
<location>
<position position="99"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="102"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="103"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 7 9">
<location>
<position position="140"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="145"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="157"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="160"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="164"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9">
<location>
<position position="234"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="987"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="1067"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="1068"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1070"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 9">
<location>
<position position="1640"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="1843"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="1942"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 3 7 8 9">
<location>
<position position="1970"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 3 9">
<location>
<position position="1974"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 9">
<location>
<position position="1998"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 9">
<location>
<position position="2002"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="2006"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 8">
<location>
<position position="2007"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="2014"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 4 8 9">
<location>
<position position="2020"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="9">
<location>
<position position="2035"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="2036"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 6 7 8 9">
<location>
<position position="2041"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 6 7 8 9">
<location>
<position position="2043"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="4">
<location>
<position position="2045"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_023058" evidence="28">
<location>
<begin position="1"/>
<end position="458"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_007869" evidence="32">
<location>
<begin position="1"/>
<end position="331"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_007870" evidence="32">
<original>SD</original>
<variation>MR</variation>
<location>
<begin position="332"/>
<end position="333"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_007871" evidence="27">
<location>
<begin position="1571"/>
<end position="1607"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3, isoform 4 and isoform 5." id="VSP_007872" evidence="27 28 30">
<location>
<begin position="1952"/>
<end position="1966"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs8076604." id="VAR_030585" evidence="16 18 26">
<original>A</original>
<variation>V</variation>
<location>
<position position="958"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with actin." evidence="17">
<original>RG</original>
<variation>AA</variation>
<location>
<begin position="114"/>
<end position="115"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with actin." evidence="17">
<original>VL</original>
<variation>AA</variation>
<location>
<begin position="117"/>
<end position="118"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAD66838 and 2; AAV80770." ref="1 2" evidence="32">
<original>A</original>
<variation>V</variation>
<location>
<position position="1014"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAI45931." ref="4" evidence="32">
<original>S</original>
<variation>P</variation>
<location>
<position position="1020"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAI45931." ref="4" evidence="32">
<original>E</original>
<variation>K</variation>
<location>
<position position="1757"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAI45931." ref="4" evidence="32">
<original>E</original>
<variation>G</variation>
<location>
<position position="1889"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18088087"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18318008"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250"/>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9JMH9"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255"/>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00116"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00143"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10733938"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15835906"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16087679"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18854160"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19837035"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21123169"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23345592"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23990465"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25965346"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27467939"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9039502"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15491607"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16087679"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="27467939"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000305"/>
<sequence length="2054" mass="233115" checksum="52BFA0AA273E18F7" modified="2003-07-25" version="3">
MFNLMKKDKDKDGGRKEKKEKKEKKERMSAAELRSLEEMSLRRGFFNLNRSSKRESKTRL
EISNPIPIKVASGSDLHLTDIDSDSNRGSVILDSGHLSTASSSDDLKGEEGSFRGSVLQR
AAKFGSLAKQNSQMIVKRFSFSQRSRDESASETSTPSEHSAAPSPQVEVRTLEGQLVQHP
GPGIPRPGHRSRAPELVTKKFPVDLRLPPVVPLPPPTLRELELQRRPTGDFGFSLRRTTM
LDRGPEGQACRRVVHFAEPGAGTKDLALGLVPGDRLVEINGHNVESKSRDEIVEMIRQSG
DSVRLKVQPIPELSELSRSWLRSGEGPRREPSDAKTEEQIAAEEAWNETEKVWLVHRDGF
SLASQLKSEELNLPEGKVRVKLDHDGAILDVDEDDVEKANAPSCDRLEDLASLVYLNESS
VLHTLRQRYGASLLHTYAGPSLLVLGPRGAPAVYSEKVMHMFKGCRREDMAPHIYAVAQT
AYRAMLMSRQDQSIILLGSSGSGKTTSCQHLVQYLATIAGISGNKVFSVEKWQALYTLLE
AFGNSPTIINGNATRFSQILSLDFDQAGQVASASIQTMLLEKLRVARRPASEATFNVFYY
LLACGDGTLRTELHLNHLAENNVFGIVPLAKPEEKQKAAQQFSKLQAAMKVLGISPDEQK
ACWFILAAIYHLGAAGATKEAAEAGRKQFARHEWAQKAAYLLGCSLEELSSAIFKHQHKG
GTLQRSTSFRQGPEESGLGDGTGPKLSALECLEGMAAGLYSELFTLLVSLVNRALKSSQH
SLCSMMIVDTPGFQNPEQGGSARGASFEELCHNYTQDRLQRLFHERTFVQELERYKEENI
ELAFDDLEPPTDDSVAAVDQASHQSLVRSLARTDEARGLLWLLEEEALVPGASEDTLLER
LFSYYGPQEGDKKGQSPLLHSSKPHHFLLGHSHGTNWVEYNVTGWLNYTKQNPATQNAPR
LLQDSQKKIISNLFLGRAGSATVLSGSIAGLEGGSQLALRRATSMRKTFTTGMAAVKKKS
LCIQMKLQVDALIDTIKKSKLHFVHCFLPVAEGWAGEPRSASSRRVSSSSELDLPSGDHC
EAGLLQLDVPLLRTQLRGSRLLDAMRMYRQGYPDHMVFSEFRRRFDVLAPHLTKKHGRNY
IVVDERRAVEELLECLDLEKSSCCMGLSRVFFRAGTLARLEEQRDEQTSRNLTLFQAACR
GYLARQHFKKRKIQDLAIRCVQKNIKKNKGVKDWPWWKLFTTVRPLIEVQLSEEQIRNKD
EEIQQLRSKLEKAEKERNELRLNSDRLESRISELTSELTDERNTGESASQLLDAETAERL
RAEKEMKELQTQYDALKKQMEVMEMEVMEARLIRAAEINGEVDDDDAGGEWRLKYERAVR
EVDFTKKRLQQEFEDKLEVEQQNKRQLERRLGDLQADSEESQRALQQLKKKCQRLTAELQ
DTKLHLEGQQVRNHELEKKQRRFDSELSQAHEEAQREKLQREKLQREKDMLLAEAFSLKQ
QLEEKDMDIAGFTQKVVSLEAELQDISSQESKDEASLAKVKKQLRDLEAKVKDQEEELDE
QAGTIQMLEQAKLRLEMEMERMRQTHSKEMESRDEEVEEARQSCQKKLKQMEVQLEEEYE
DKQKVLREKRELEGKLATLSDQVNRRDFESEKRLRKDLKRTKALLADAQLMLDHLKNSAP
SKREIAQLKNQLEESEFTCAAAVKARKAMEVEIEDLHLQIDDIAKAKTALEEQLSRLQRE
KNEIQNRLEEDQEDMNELMKKHKAAVAQASRDLAQINDLQAQLEEANKEKQELQEKLQAL
QSQVEFLEQSMVDKSLVSRQEAKIRELETRLEFERTQVKRLESLASRLKENMEKLTEERD
QRIAAENREKEQNKRLQRQLRDTKEEMGELARKEAEASRKKHELEMDLESLEAANQSLQA
DLKLAFKRIGDLQAAIEDEMESDENEDLINSLQDMVTKYQKRKNKLEGDSDVDSELEDRV
DGVKSWLSKNKGPSKAASDDGSLKSSSPTSYWKSLAPDRSDDEHDPLDNTSRPRYSHSYL
SDSDTEAKLTETNA
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>